UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 46,986,408
- Total 13F shares
- 5,741,200
- Share change
- +2,199,812
- Total reported value
- $213,691,000
- Price per share
- $37.21
- Number of holders
- 40
- Value change
- +$83,149,343
- Number of buys
- 25
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M96088105:
Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
1.6%
|
769,230
|
$24,246,000 | — | 30 Sep 2017 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
1.2%
|
569,589
|
$17,953,000 | — | 30 Sep 2017 | |
| HIGHLINE CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.87%
|
410,000
|
$12,923,000 | — | 30 Sep 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.62%
|
289,262
|
$9,118,000 | — | 30 Sep 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.57%
|
269,014
|
$8,479,000 | — | 30 Sep 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.32%
|
148,575
|
$4,683,000 | — | 30 Sep 2017 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
0.29%
|
135,000
|
$4,255,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.21%
|
100,000
|
$3,152,000 | — | 30 Sep 2017 | |
| DSAM Partners (London) Ltd |
13F
|
Company |
0.16%
|
74,500
|
$2,348,000 | — | 30 Sep 2017 | |
| BAINCO INTERNATIONAL INVESTORS |
13F
|
Company |
0.15%
|
72,461
|
$2,284,000 | — | 30 Sep 2017 | |
| Lyon Street Capital, LLC |
13F
|
Company |
0.09%
|
41,741
|
$1,316,000 | — | 30 Sep 2017 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.08%
|
38,461
|
$1,212,000 | — | 30 Sep 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.08%
|
37,100
|
$1,169,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
25,600
|
$807,000 | — | 30 Sep 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
24,593
|
$775,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
23,656
|
$746,000 | — | 30 Sep 2017 | |
| SHIKIAR ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
21,100
|
$665,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
16,376
|
$516,000 | — | 30 Sep 2017 | |
| J.P. Morgan Private Wealth Advisors LLC |
13F
|
Company |
0.03%
|
12,250
|
$386,000 | — | 30 Sep 2017 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.03%
|
11,790
|
$372,000 | — | 30 Sep 2017 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.02%
|
9,300
|
$293,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
7,145
|
$225,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
5,171
|
$168,000 | — | 30 Sep 2017 | |
| State of Tennessee, Department of Treasury |
13F
|
Company |
0.01%
|
5,010
|
$158,000 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,750
|
$55,000 | — | 30 Sep 2017 | |
| ProQuest Associates IV LLC |
13F
|
Company |
3.1%
|
1,449,745
|
$45,696 | — | 30 Sep 2017 | |
| NORGES BANK |
13F
|
Company |
0%
|
1,334
|
$42,000 | — | 30 Sep 2017 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
800
|
$35,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,000
|
$32,000 | — | 30 Sep 2017 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
380
|
$12,000 | — | 30 Sep 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
318
|
$10,000 | — | 30 Sep 2017 |
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q4 2017
As of 31 Dec 2017,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,741,200 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., Consonance Capital Management LP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, MEITAV DASH INVESTMENTS LTD, HIGHLINE CAPITAL MANAGEMENT, L.P., CREDIT SUISSE AG/, PERCEPTIVE ADVISORS LLC, DSAM Partners (London) Ltd, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
29
Q4 2017 holders
40
Holder diff
11
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.